Advanced Search
Contact | Corporate | Help

Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sponsors:
  • National Taiwan University Hospital
  • GlaxoSmithKline
Phases:
  • Phase II
IndicationsAcronym:
  • Head and Neck Squamous Cell Carcinoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Pazopanib
Enrollment:
45

Additional information about NCT01377298.


SourceSolution © 2008-2012